Tumor necrosis factor-α inhibits myogenesis through redox-dependent and -independent pathways

American Journal of Physiology - Cell Physiology

Volumn 283, Issue 3 52-3, 2002, Pages

  Langen, Ramon C J ^a   Schols, Annemie M W J ^a   Kelders, Marco C J M ^a   Van Der Velden, Jos L J ^a   Wouters, Emiel F M ^a   Janssen Heininger, Yvonne M W ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Glutathione; Inflammation; Myogenic differentiation; Myotube; Nuclear factor B

Indexed keywords

ACETYLCYSTEINE; CYTOKINE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SPECIFICITY; CONTROLLED STUDY; INFLAMMATION; MOUSE; MUSCLE DEVELOPMENT; MYOTUBE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALIA;

EID: 0036720492     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00418.2001     Document Type: Article

References (41)

1. Wasting as independent risk factor for mortality in chronic heart failure
2. The role of cytokines in cancer cachexia
3. Increased tumor necrosis factor-alpha serum levels in patients with HIV wasting syndrome and euthyroid sick syndrome
4. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases
5. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants
6. Reactive oxygen species are downstream products of TRAF-mediated signal transduction
7. Cell membrane redox systems and transformation
8. A fluorometric assay for glutathione
9. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease
10. Tumour necrosis factor-alpha, resting energy expenditure and cachexia in cystic fibrosis
11. Cachectin/TNF or IL-1α induces cachexia with redistribution of body proteins
12. Regulation of antioxidant enzyme gene expression in response to oxidative stress and during differentiation of mouse skeletal muscle
13. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
14. Recruitment of beta-catenin to cadherin-mediated intercellular adhesions is involved in myogenic induction
15. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1
16. Differential induction of c-fos, c-jun, and apoptosis in lung epithelial cells exposed to ROS or RNS
17. Proinflammatory cytokines regulate myogenic cell proliferation and fusion but have no impact on myotube protein metabolism or stress protein expression
18. Redox regulation of cellular signalling
19. The M-cadherin catenin complex interacts with microtubules in skeletal muscle cells: Implications for the fusion of myoblasts
20. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS
21. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB
22. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts
23. Is NF-kappaB the sensor of oxidative stress?
24. Mitochondria mediate tumor necrosis factor alpha/NF-kappaB signaling in skeletal muscle myotubes
25. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha
26. Tumor necrosis factor inhibits human myogenesis in vitro
27. Robert H. Herman Memorial Award in Clinical Nutrition Lecture, 1997. Mechanisms causing loss of lean body mass in kidney disease
28. Muscle wasting in emphysema
29. Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer
30. Activators and target genes of Rel/NF-kappaB transcription factors
31. Chemically induced oxidative stress disrupts the E-cadherin/catenin cell adhesion complex
32. Nitric oxide, reactive oxygen species, and skeletal muscle contraction
33. Mitochondrial activity is involved in the regulation of myoblast differentiation through myogenin expression and activity of myogenic factors
34. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease
35. Glutathione regulation of tumor necrosis factor-alpha-induced NF-kappa B activation in skeletal muscle-derived L6 cells
36. Free radical induced respiratory muscle dysfunction
37. TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin
38. 12 skeletal muscle myocytes
39. Body weight in chronic obstructive pulmonary disease
40. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
41. Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia